These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35094011)

  • 1. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m
    Xu QC; Tien YC; Shi YH; Chen S; Zhu YQ; Huang XT; Huang CS; Zhao W; Yin XY
    Oncogene; 2022 Mar; 41(11):1622-1633. PubMed ID: 35094011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
    Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
    J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
    Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
    Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.
    Gao J; Fang Y; Chen J; Tang Z; Tian M; Jiang X; Tao C; Huang R; Zhu G; Qu W; Wu X; Zhou J; Fan J; Liu W; Shi Y
    Oncogene; 2023 Aug; 42(33):2507-2520. PubMed ID: 37420030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner.
    Chen Y; Liu X; Li L; He X; Zheng F; Zhang Y; Gao H; Jin Z; Wu D; Wang Q; Tao H; Zhao Y; Liu W; Zou L
    Mol Med; 2023 Feb; 29(1):19. PubMed ID: 36747144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export.
    Li D; Cai L; Meng R; Feng Z; Xu Q
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
    Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
    Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5.
    Zhou D; Tang W; Xu Y; Xu Y; Xu B; Fu S; Wang Y; Chen F; Chen Y; Han Y; Wang G
    Mol Oncol; 2021 Aug; 15(8):2172-2184. PubMed ID: 33411363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.
    Chen HD; Li F; Chen S; Zhong ZH; Gao PF; Gao WZ
    Cancer Gene Ther; 2022 Jul; 29(7):1012-1020. PubMed ID: 34799724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway.
    Xiang D; Gu M; Liu J; Dong W; Yang Z; Wang K; Fu J; Wang H
    Cancer Lett; 2023 Apr; 560():216144. PubMed ID: 36958694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The m
    Qin Y; Qiao Y; Li L; Luo E; Wang D; Yao Y; Tang C; Yan G
    Life Sci; 2021 Jun; 274():119366. PubMed ID: 33741419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3/YTHDF2 m
    Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
    J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 mediates osteoblast apoptosis by regulating endoplasmic reticulum stress during LPS-induced inflammation.
    Kong Y; Zhang Y; Cai Y; Li D; Yi B; Xu Q
    Cell Signal; 2022 Jul; 95():110335. PubMed ID: 35461899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.
    Li J; Xu X; Xu K; Zhou X; Wu K; Yao Y; Liu Z; Chen C; Wang L; Sun Z; Jiao D; Han X
    J Exp Clin Cancer Res; 2024 Apr; 43(1):119. PubMed ID: 38641828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LINC00470 promotes the degradation of PTEN mRNA to facilitate malignant behavior in gastric cancer cells.
    Yan J; Huang X; Zhang X; Chen Z; Ye C; Xiang W; Huang Z
    Biochem Biophys Res Commun; 2020 Jan; 521(4):887-893. PubMed ID: 31711642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3-dependent N
    Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL3-mediated N
    Zang Y; Tian Z; Wang D; Li Y; Zhang W; Ma C; Liao Z; Gao W; Qian L; Xu X; Jia J; Liu Z
    Oncogene; 2024 Jul; 43(30):2338-2354. PubMed ID: 38879589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.